Last week, consumer electronics giant Samsung filed responses to requests for Director Review by patent owner Netlist in ...

Pakistani patients deserve not only safe and high‑quality medicines but also timely access to innovative therapies ...

The USPTO cleared a patent filed in November 2023, with a status indicating it has been approved and the patent is expected ...

Company secures patent-pending status to protect novel architecture for a constant, ship-based autonomous drone interception system designed to counter drone swarm threats at a fraction of the cost of ...

Quinn Emanuel convinced the Federal Circuit to undo a contempt order and related $296 million damages enhancement based on a ...

Dormant company status allows inactive companies to maintain legal existence with minimal compliance. The provision helps businesses reduce costs while planning future ...

By introducing proprietary, patent-protected, genetically engineered porcine organs into an organ transplant system, kidney ...

QINGZHOU, SHANDONG, CHINA, March 15, 2026 /EINPresswire.com/ -- As global infrastructure investment accelerates and the ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company developing ...

NEW YORK – Novartis' key patent on its radioligand therapy Lutathera (lutetium Lu 177 dotatate) isn't set to expire until 2038, but radiopharmaceutical company Lantheus is already preparing to ...